VOYA Investment Management
ELVN icon

VOYA Investment Management’s Enliven Therapeutics ELVN Stock Holding History

VOYA Investment Management’s Portfolio ELVN Stock Details ELVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$568K Buy
+14,491
New +$401K ﹤0.01% 1671
2025
Q1 		– Sell
-10,702
Closed -$241K – 2666
2024
Q4 		$241K Sell
10,702
-945
-8% -$24.5K ﹤0.01% 2312
2024
Q3 		$297K Sell
11,647
-186
-2% -$4.31K ﹤0.01% 2264
2024
Q2 		$277K Buy
+11,833
New +$249K ﹤0.01% 2292

Other funds holding ELVN

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

VOYA Investment Management's ELVN Position: Q1 2026 in Review

VOYA Investment Management opened a new position in Enliven Therapeutics (ELVN) in Q1 2026: 14,491 shares worth $568K. The stake represents ﹤0.01% of the portfolio and ranks #1671 among its holdings. This is a return to the name: VOYA Investment Management previously reported a position in ELVN as recently as Q4 2024.

VOYA Investment Management first reported a position in ELVN in Q2 2024 and has held it in 4 quarters since. 170 funds tracked by Wall St. Rank hold ELVN as of Q1 2026.

  • VOYA Investment Management held 14,491 shares of Enliven Therapeutics worth $568K as of Q1 2026.
  • Enliven Therapeutics was a new VOYA Investment Management position in Q1 2026.
  • Enliven Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #1671 holding.
  • VOYA Investment Management first reported a position in Enliven Therapeutics in Q2 2024 and has held it in 4 quarters since.
  • 170 funds tracked by Wall St. Rank held Enliven Therapeutics as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.